Company news

ImmuneOncia Therapeutics Inc. news

Latest news releases, newest first.

ImmuneOncia Announces Interim Results from Phase 1b Clinical Trial of Next-Generation CD47 Antibody 'IMC-002' at ASCO 2025

June 2, 2025